Nantahala-Capital-Management

AI_NATIVE detailed information: This accession holds the following tickers:[
  "CNTA",
  "NKTR",
  "SVC",
  "ABVX",
  "HGV",
  "RMBL",
  "TITN",
  "RCKT",
  "ATXS",
  "RMR",
  "TNGX",
  "GPCR",
  "SLN",
  "SVRA",
  "THRD",
  "TRML",
  "ACHV",
  "MLYS",
  "SNDX",
  "ABEO",
  "KROS",
  "AKBA",
  "ASPS",
  "ALTG",
  "AVTX",
  "AMRX",
  "AMLX",
  "APYX",
  "APRE",
  "AVR",
  "ANEB",
  "PHGE",
  "PLCE",
  "ESTA",
  "NVNO",
  "FBIO",
  "FULC",
  "CRMT",
  "HLF",
  "GORV",
  "LUCD",
  "NNBR",
  "NDLS",
  "PAYO",
  null,
  "PVLA",
  "OMI",
  "OKUR",
  "RDI",
  "RSVR",
  "RDVT",
  "SGRP",
  "SNTI",
  "TELA",
  null,
  "STKS",
  "SSKN",
  null,
  "SRZN",
  "UNCY",
  "TACT",
  "EDSA",
  "BNTC",
  "AYTU",
  "EVOK",
  null,
  "IKT",
  "RZLT",
  "SRL",
  "IMAX",
  "ZYXI",
  "GFAIW",
  null,
  null,
  null,
  "AURA",
  "UPB",
  "RAPT",
  "SLDB",
  "LXRX",
  "NPCE",
  "ACU",
  "SLNO",
  "QURE",
  "COGT",
  "KOS",
  "DYN",
  "OLPX",
  "SCPH",
  "PTON",
  "GOGO",
  "RH",
  null,
  "CMPS",
  "CNTX",
  "ELDN",
  null,
  "EHTH",
  "FOSL",
  "EOLS",
  "EYPT",
  "FOXF",
  "XGN",
  "GAIA",
  "EB",
  null,
  "ILPT",
  null,
  "KOD",
  "ETON",
  "URGN",
  "VSTM",
  "VTGN",
  "VMD",
  null,
  "XTNT",
  "DRIO",
  "XNCR",
  "OPTN",
  "LADR",
  "LYV",
  null,
  "ASRT",
  "TBBK",
  "BVS",
  "CZR",
  "CRGX",
  "CDXS",
  "CMCO",
  "DHX",
  "IRON",
  "QQQ",
  "IWM"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 133
Total Value: 2187261798
Accession Number: 0001104659-25-049574
Form Type: 13F-HR
CIK: nantahala-capital-management
Manager Name: Nantahala-Capital-Management

Data Enrichment

90% identified

120 identified13 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

133 positions • $2.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 7

Sort by:

Tourmaline Bio, Inc.

TRML|89157D105

Shares:532.8K

Value:$8.1M

% of Portfolio:0.4% ($8.1M/$2.2B)

COMPASS Pathways plc

CMPS|20451W101

Shares:2.8M

Value:$8.1M

% of Portfolio:0.4% ($8.1M/$2.2B)

05479K106

Shares:3.2M

Value:$8.1M

% of Portfolio:0.4% ($8.1M/$2.2B)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:554.8K

Value:$8.0M

% of Portfolio:0.4% ($8.0M/$2.2B)

CODEXIS, INC.

CDXS|192005106

Shares:2.8M

Value:$7.6M

% of Portfolio:0.3% ($7.6M/$2.2B)

Aura Biosciences, Inc.

AURA|05153U107

Shares:1.3M

Value:$7.4M

% of Portfolio:0.3% ($7.4M/$2.2B)

Disc Medicine, Inc.

IRON|254604101

Shares:148.4K

Value:$7.4M

% of Portfolio:0.3% ($7.4M/$2.2B)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:900.0K

Value:$7.2M

% of Portfolio:0.3% ($7.2M/$2.2B)

PALVELLA THERAPEUTICS, INC.

PVLA|697947109

Shares:250.1K

Value:$7.0M

% of Portfolio:0.3% ($7.0M/$2.2B)

Syndax Pharmaceuticals Inc

SNDX|87164F105

Shares:554.5K

Value:$6.8M

% of Portfolio:0.3% ($6.8M/$2.2B)

VIEMED HEALTHCARE, INC.

VMD|92663R105

Shares:932.4K

Value:$6.8M

% of Portfolio:0.3% ($6.8M/$2.2B)

ONE Group Hospitality, Inc.

STKS|88338K103

Shares:2.1M

Value:$6.3M

% of Portfolio:0.3% ($6.3M/$2.2B)

45779A846

Shares:2.3M

Value:$6.2M

% of Portfolio:0.3% ($6.2M/$2.2B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:5.0M

Value:$6.1M

% of Portfolio:0.3% ($6.1M/$2.2B)

Anteris Technologies Global Corp.

AVR|03675P102

Shares:1.7M

Value:$5.9M

% of Portfolio:0.3% ($5.9M/$2.2B)

Assertio Holdings, Inc.

ASRT|04546C205

Shares:8.4M

Value:$5.7M

% of Portfolio:0.3% ($5.7M/$2.2B)

Unicycive Therapeutics, Inc.

UNCY|90466Y103

Shares:9.4M

Value:$5.4M

% of Portfolio:0.2% ($5.4M/$2.2B)

Xtant Medical Holdings, Inc.

XTNT|98420P308

Shares:11.4M

Value:$5.4M

% of Portfolio:0.2% ($5.4M/$2.2B)

NEKTAR THERAPEUTICS

NKTR|640268108

Shares:7.8M

Value:$5.3M

% of Portfolio:0.2% ($5.3M/$2.2B)

Cogent Biosciences, Inc.

COGT|19240Q201

Shares:843.5K

Value:$5.1M

% of Portfolio:0.2% ($5.1M/$2.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Tourmaline Bio, Inc.(TRMLcusip89157D105)	532.8K	QoQ -0.76% (-4.1K) YoY -23.98% (-168.1K)	All Managers (Combined)	$8.1M	0.4% ($8.1M/$2.2B)	QoQ -25.57% (-$2.8M) YoY -49.50% (-$7.9M)
COMPASS Pathways plc(CMPScusip20451W101)	2.8M	QoQ +182.92% (+1.8M) YoY NEW(+2.8M)	All Managers (Combined)	$8.1M	0.4% ($8.1M/$2.2B)	QoQ +114.06% (+$4.3M) YoY NEW(+$8.1M)
(cusip05479K106)✕	3.2M	QoQ +11.16% (-320.0K) YoY +93.02% (+1.5M)	All Managers (Combined)	$8.1M	0.4% ($8.1M/$2.2B)	QoQ -24.79% (-$2.7M) YoY +55.03% (+$2.9M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	554.8K	QoQ +8.22% (-42.2K) YoY NEW(+554.8K)	All Managers (Combined)	$8.0M	0.4% ($8.0M/$2.2B)	QoQ -7.08% (-$608.8K) YoY NEW(+$8.0M)
CODEXIS, INC.(CDXScusip192005106)	2.8M	QoQ -0.38% (-11.0K) YoY -36.55% (-1.6M)	All Managers (Combined)	$7.6M	0.3% ($7.6M/$2.2B)	QoQ -43.82% (-$5.9M) YoY -51.10% (-$8.0M)
Aura Biosciences, Inc.(AURAcusip05153U107)	1.3M	QoQ -0.18% (-2.3K) YoY -4.09% (-54.2K)	All Managers (Combined)	$7.4M	0.3% ($7.4M/$2.2B)	QoQ -28.84% (-$3.0M) YoY -28.40% (-$2.9M)
Disc Medicine, Inc.(IRONcusip254604101)	148.4K	QoQ -1.07% (-1.6K) YoY NEW(+148.4K)	All Managers (Combined)	$7.4M	0.3% ($7.4M/$2.2B)	QoQ -22.54% (-$2.1M) YoY NEW(+$7.4M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	900.0K	QoQ NEW(+900.0K) YoY NEW(+900.0K)	All Managers (Combined)	$7.2M	0.3% ($7.2M/$2.2B)	QoQ NEW(+$7.2M) YoY NEW(+$7.2M)
PALVELLA THERAPEUTICS, INC.(PVLAcusip697947109)	250.1K	QoQ 0.00% (+0) YoY NEW(+250.1K)	All Managers (Combined)	$7.0M	0.3% ($7.0M/$2.2B)	QoQ +133.24% (+$4.0M) YoY NEW(+$7.0M)
Syndax Pharmaceuticals Inc(SNDXcusip87164F105)	554.5K	QoQ -1.07% (-6.0K) YoY +19.18% (-89.2K)	All Managers (Combined)	$6.8M	0.3% ($6.8M/$2.2B)	QoQ -8.07% (-$598.2K) YoY -38.48% (-$4.3M)
VIEMED HEALTHCARE, INC.(VMDcusip92663R105)	932.4K	QoQ -0.28% (-2.7K) YoY -39.84% (-617.7K)	All Managers (Combined)	$6.8M	0.3% ($6.8M/$2.2B)	QoQ -9.48% (-$711.5K) YoY -53.56% (-$7.8M)
ONE Group Hospitality, Inc.(STKScusip88338K103)	2.1M	QoQ +1.61% (+33.7K) YoY +287.26% (+1.6M)	All Managers (Combined)	$6.3M	0.3% ($6.3M/$2.2B)	QoQ +4.76% (+$288.6K) YoY +107.88% (+$3.3M)
(cusip45779A846)✕	2.3M	QoQ +38.42% (+643.5K) YoY +12.17% (+251.6K)	All Managers (Combined)	$6.2M	0.3% ($6.2M/$2.2B)	QoQ +41.58% (+$1.8M) YoY +27.31% (+$1.3M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	5.0M	QoQ +303.12% (+3.8M) YoY NEW(+5.0M)	All Managers (Combined)	$6.1M	0.3% ($6.1M/$2.2B)	QoQ +211.27% (+$4.2M) YoY NEW(+$6.1M)
Anteris Technologies Global Corp.(AVRcusip03675P102)	1.7M	QoQ -0.18% (-3.0K) YoY NEW(+1.7M)	All Managers (Combined)	$5.9M	0.3% ($5.9M/$2.2B)	QoQ -36.04% (-$3.4M) YoY NEW(+$5.9M)
Assertio Holdings, Inc.(ASRTcusip04546C205)	8.4M	QoQ +3.57% (-291.4K) YoY -8.96% (-831.1K)	All Managers (Combined)	$5.7M	0.3% ($5.7M/$2.2B)	QoQ -19.78% (-$1.4M) YoY -35.98% (-$3.2M)
Unicycive Therapeutics, Inc.(UNCYcusip90466Y103)	9.4M	QoQ -9.62% (-1.0M) YoY +181.56% (-6.1M)	All Managers (Combined)	$5.4M	0.2% ($5.4M/$2.2B)	QoQ -34.57% (-$2.9M) YoY -37.53% (-$3.2M)
Xtant Medical Holdings, Inc.(XTNTcusip98420P308)	11.4M	QoQ 0.00% (+0) YoY +184.85% (+7.4M)	All Managers (Combined)	$5.4M	0.2% ($5.4M/$2.2B)	QoQ +6.09% (+$307.6K) YoY +14.42% (+$675.2K)
NEKTAR THERAPEUTICS(NKTRcusip640268108)	7.8M	QoQ -0.26% (-20.9K) YoY +214.58% (+5.3M)	All Managers (Combined)	$5.3M	0.2% ($5.3M/$2.2B)	QoQ -27.07% (-$2.0M) YoY +128.98% (+$3.0M)
Cogent Biosciences, Inc.(COGTcusip19240Q201)	843.5K	QoQ -1.09% (-9.4K) YoY +6.64% (-52.6K)	All Managers (Combined)	$5.1M	0.2% ($5.1M/$2.2B)	QoQ -24.04% (-$1.6M) YoY -4.94% (-$262.6K)